🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07823400
Recruiting Observational

MIECC vs Conventional Cardiopulmonary Bypass and Systemic Inflammation in CABG

NCT07823400 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-02-07
Last updated
2026-09-16

Condition(s) studied

Coronary Artery DiseaseSystemic Inflammation

Investigational drug(s) / intervention(s)

Minimally Invasive Extracorporeal CirculationConventional Cardiopulmonary Bypass

Minimally Invasive Extracorporeal Circulation: Use of a minimally invasive extracorporeal circulation system during coronary artery bypass graft surgery as part of routine clinical care.

Conventional Cardiopulmonary Bypass: Use of conventional cardiopulmonary bypass during coronary artery bypass graft surgery as part of routine clinical care.

Study summary

This prospective observational study evaluates the effects of minimally invasive extracorporeal circulation (MIECC) and conventional cardiopulmonary bypass on systemic inflammatory response in patients undergoing coronary artery bypass graft surgery. Adult patients undergoing elective coronary artery bypass surgery will be observed according to the extracorporeal circulation technique used during surgery. Systemic inflammation will be assessed using routinely available hematologic inflammatory indices, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII). These parameters will be evaluated preoperatively, at postoperative 6 hours, at postoperative 24 hours, and at hospital discharge. The study will also evaluate selected perioperative and postoperative clinical outcomes in order to compare the inflammatory response associated with MIECC and conventional extracorporeal circulation.

Eligibility

Sex
ALL
Min age
30 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Age 30-70 years * Patients undergoing elective coronary artery bypass graft surgery * Patients in whom cardiopulmonary bypass is planned * Written informed consent obtained Exclusion Criteria: * Emergency surgery * Redo cardiac surgery * Concomitant valve surgery * Previous open heart surgery * Preoperative renal and/or hepatic failure * Malignancy * Active infection or inflammatory disease-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bursa Yuksek Ihtisas Training and Research Hospital Bursa Bursa Recruiting

More Bursa Yuksek Ihtisas Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07823400 on ClinicalTrials.gov ↗ ← All trials in Turkey